Darwin Global Management, Ltd.
Darwin Global Management, Ltd. reported 5 holdings worth US$3.99B as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Darwin Global Management, Ltd. reported 5 holdings worth US$3.99B as of Sep 30, 2026. Largest: Revolution Medicines, Inc., Genmab A/S and Belite Bio, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 5
- Value as reported
- US$3.99B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Revolution Medicines, Inc. | 10.6M | US$2.18B | 54.7% |
| Genmab A/S | 17.9M | US$639M | 16.0% |
| Belite Bio, Inc. | 3.1M | US$526M | 13.2% |
| Abivax SA | 4.02M | US$398M | 10.0% |
| Roivant Sciences Ltd. | 6.75M | US$247M | 6.2% |
| Insmed Incorporated | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC